49 related articles for article (PubMed ID: 9013574)
1. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system.
Rachez C; Suldan Z; Ward J; Chang CP; Burakov D; Erdjument-Bromage H; Tempst P; Freedman LP
Genes Dev; 1998 Jun; 12(12):1787-800. PubMed ID: 9637681
[TBL] [Abstract][Full Text] [Related]
2. Structure of the ligand-binding domain of rat VDR in complex with the nonsecosteroidal vitamin D3 analogue YR301.
Kakuda S; Okada K; Eguchi H; Takenouchi K; Hakamata W; Kurihara M; Takimoto-Kamimura M
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Nov; 64(Pt 11):970-3. PubMed ID: 18997319
[TBL] [Abstract][Full Text] [Related]
3. The vitamin D receptor interacts preferentially with DRIP205-like LxxLL motifs.
Zella LA; Chang CY; McDonnell DP; Pike JW
Arch Biochem Biophys; 2007 Apr; 460(2):206-12. PubMed ID: 17254542
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Biological Evaluation of New Type of Gemini Analogues with a Cyclopropane Moiety in Their Side Chain.
Gómez-Bouzó U; Peluso-Iltis C; Santalla H; Quevedo MA; Verlinden L; Verstuyf A; Fall Y; Gómez G; Rochel N
J Med Chem; 2024 Jun; ():. PubMed ID: 38858308
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and Its Synthetic Analogs.
Maestro MA; Molnár F; Carlberg C
J Med Chem; 2019 Aug; 62(15):6854-6875. PubMed ID: 30916559
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological action of 20R-hydroxyvitamin D3.
Lu Y; Chen J; Janjetovic Z; Michaels P; Tang EK; Wang J; Tuckey RC; Slominski AT; Li W; Miller DD
J Med Chem; 2012 Apr; 55(7):3573-7. PubMed ID: 22404326
[TBL] [Abstract][Full Text] [Related]
7. Calcitriol derivatives with two different side chains at C-20. V. Potent inhibitors of mammary carcinogenesis and inducers of leukemia differentiation.
Maehr H; Lee HJ; Perry B; Suh N; Uskokovic MR
J Med Chem; 2009 Sep; 52(17):5505-19. PubMed ID: 19685888
[TBL] [Abstract][Full Text] [Related]
8. The enhanced hypercalcemic response to 20-epi-1,25-dihydroxyvitamin D3 results from a selective and prolonged induction of intestinal calcium-regulating genes.
Zella LA; Meyer MB; Nerenz RD; Pike JW
Endocrinology; 2009 Aug; 150(8):3448-56. PubMed ID: 19423758
[TBL] [Abstract][Full Text] [Related]
9. Conservative mutageneic perturbations of amino acids connecting helix 12 in the 1alpha,25(OH)2-D3 receptor (VDR) to the ligand cause significant transactivational effects.
Bula CM; Bishop JE; Norman AW
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):286-92. PubMed ID: 17368178
[TBL] [Abstract][Full Text] [Related]
10. Difluoromethyl analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: Design, synthesis, and preliminary biological evaluation.
Posner GH; Suh BC; Petersen KS; Dolan P; Agoston ES; Kensler TW; Koh JT; Peleg S
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):213-21. PubMed ID: 17218093
[TBL] [Abstract][Full Text] [Related]
11. Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling.
Mizwicki MT; Keidel D; Bula CM; Bishop JE; Zanello LP; Wurtz JM; Moras D; Norman AW
Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12876-81. PubMed ID: 15326291
[TBL] [Abstract][Full Text] [Related]
12. Structure function studies: identification of vitamin D analogs for the ligand-binding domains of important proteins in the vitamin D-endocrine system.
Norman AW; Silva FR
Rev Endocr Metab Disord; 2001 Apr; 2(2):229-38. PubMed ID: 11705328
[No Abstract] [Full Text] [Related]
13. Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands.
Tocchini-Valentini G; Rochel N; Wurtz JM; Mitschler A; Moras D
Proc Natl Acad Sci U S A; 2001 May; 98(10):5491-6. PubMed ID: 11344298
[TBL] [Abstract][Full Text] [Related]
14. Functional conformations of the nuclear 1alpha,25-dihydroxyvitamin D3 receptor.
Nayeri S; Carlberg C
Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):561-8. PubMed ID: 9359430
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1beta production.
Peleg S; Qiu H; Reddy S; Harris D; Van Q; Estey EH; Talpaz M; Estrov Z
J Clin Invest; 1997 Oct; 100(7):1716-24. PubMed ID: 9312169
[TBL] [Abstract][Full Text] [Related]
16. Differential interaction of 1alpha,25-dihydroxyvitamin D3 analogues and their 20-epi homologues with the vitamin D receptor.
Liu YY; Collins ED; Norman AW; Peleg S
J Biol Chem; 1997 Feb; 272(6):3336-45. PubMed ID: 9013574
[TBL] [Abstract][Full Text] [Related]
17. Gene regulatory potential of 1alpha,25-dihydroxyvitamin D(3) analogues with two side chains.
Bury Y; Herdick M; Uskokovic MR; Carlberg C
J Cell Biochem Suppl; 2001; Suppl 36():179-90. PubMed ID: 11455583
[TBL] [Abstract][Full Text] [Related]
18. Distinct conformational changes induced by 20-epi analogues of 1 alpha,25-dihydroxyvitamin D3 are associated with enhanced activation of the vitamin D receptor.
Peleg S; Sastry M; Collins ED; Bishop JE; Norman AW
J Biol Chem; 1995 May; 270(18):10551-8. PubMed ID: 7737990
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
